Role of Salbutamol and Furosemide in TTN

July 5, 2017 updated by: arshad khushdil, Armed Forces Hospital, Pakistan

Role of Salbutamol and Furosemide in Transient Tachypnea of Newborn

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Rawalpindi, Punjab, Pakistan, 68000
        • Department of Pediatrics
      • Rawalpindi, Punjab, Pakistan, 68000
        • Military Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • all newborn babies with clinically diagnosed TTN

Exclusion Criteria:

  • babies less than 34 weeks babies with congenital malformations and CHD

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: with salbutamol
Drug: Furosemide Injection
efficacy of salbutamol and furosemide in TTN
Other Names:
  • salbutamol inhalation
Experimental: with furosemide
Drug: Furosemide Injection
efficacy of salbutamol and furosemide in TTN
Other Names:
  • salbutamol inhalation
Experimental: both furosemide and salbutamol
Drug: Furosemide Injection
efficacy of salbutamol and furosemide in TTN
Other Names:
  • salbutamol inhalation
No Intervention: no inervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
duration of oxygen requiremment in neonates having TTN.
Time Frame: upto 6 months
neonates will be subjected to treatment with furosemide and sabutamol and the duration of oxygen dependecy will be assessed.
upto 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Armed Forces Hospital, Pakistan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2016

Primary Completion (Actual)

May 30, 2017

Study Completion (Actual)

June 30, 2017

Study Registration Dates

First Submitted

July 1, 2017

First Submitted That Met QC Criteria

July 5, 2017

First Posted (Actual)

July 6, 2017

Study Record Updates

Last Update Posted (Actual)

July 6, 2017

Last Update Submitted That Met QC Criteria

July 5, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TTN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transient Tachypnea of the Newborn

Clinical Trials on Furosemide Injection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe